Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.

Hartley, James Leon; Bailey, Neil; Sharma, Asheesh; Shawki, Howida

Hartley, James Leon; Bailey, Neil; Sharma, Asheesh; Shawki, Howida.

Hartley JL; Nephrology, Royal Liverpool University Hospital, Liverpool, UK james.hartley@rlbuht.nhs.uk.
Bailey N; Nephrology, Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, UK.
Sharma A; Nephrology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
Shawki H; Histopathology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.

BMJ Case Rep ; 15(3)2022 Mar 04.

Article in English | MEDLINE | ID: covidwho-1731265

ABSTRACT

ABSTRACT

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

Subject(s)

COVID-19; Nephrosis, Lipoid; Nephrotic Syndrome; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Nephrosis, Lipoid/chemically induced; Nephrotic Syndrome/etiology; SARS-CoV-2

Keywords

COVID-19; immunological products and vaccines; nephrotic syndrome; renal system; vaccination/immunisation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Nephrosis, Lipoid / Nephrotic Syndrome Type of study: Case report / Observational study Topics: Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Bcr-2021-244638

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google